Patient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their Caregivers

Thyroid Gland Medullary Carcinoma Clinical Trial

Official title: Designing a Decision Aid to Help People With Medullary Thyroid Cancer Make Decisions With Their Doctors About Whether to Start or Stop New Drugs, Enroll in Clinical Trials, or Continue With Active Surveillance

Status Recruiting

Clinical Trial Summary

This trial develops and studies how well a patient decision aid works in supporting decision-making about when to start or stop new drugs, join clinical trials, or continue active cancer monitoring for patients with medullary thyroid cancer and their caregivers. Developing a patient decision aid may help patients with medullary thyroid cancer make well-informed decisions about their cancer care and be able to discuss their preferences with their doctors.

Clinical Trial Description

PRIMARY OBJECTIVES: I. To assess patient/survivor, caregiver/family member, and provider decision-making needs. II. To design and develop an initial patient decision aid prototype. III. To pilot test its acceptability. IV. To evaluate the acceptability and usability of the decision aid prototype from patients/survivors, caregivers and providers in a real world environment. OUTLINE: Participants use decision aid and complete questionnaire. ;

Related Conditions & MeSH terms

• Thyroid Diseases
• Thyroid Gland Medullary Carcinoma
• Thyroid Neoplasms

• NCT number: NCT03892993
• Study type: Interventional
• Source: M.D. Anderson Cancer Center
• Contact: Elizabeth G Grubbs, MD
• Phone: (713) 792-0665
• Email: eggrubbs@mdanderson.org
• Status: Recruiting
• Phase: N/A
• Start date: April 9, 2019
• Completion date: August 1, 2028